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eriplakin forms part of the scaffold onto which the
epidermal corniﬁed envelope is assembled. The NH
 
2
 
-
terminal 133 amino acids mediate association with
the plasma membrane and bind a novel protein, kazrin.
Kazrin is highly conserved and lacks homology to any known
protein. There are four alternatively spliced transcripts,
encoding three proteins with different NH
 
2
 
 termini. Kazrin
is expressed in all layers of stratiﬁed squamous epithelia; it
becomes membrane associated in the suprabasal layers,
P
 
coincident with up-regulation of periplakin, and is incor-
porated into the corniﬁed envelope of cultured keratinocytes.
Kazrin colocalizes with periplakin and desmoplakin at
desmosomes and with periplakin at the interdesmosomal
plasma membrane, but its subcellular distribution is inde-
pendent of periplakin. On transfection, all three kazrin
isoforms have similar subcellular distributions. We conclude
that kazrin is a novel component of desmosomes that asso-
ciates with periplakin.
 
Introduction
 
The cornified envelope (CE), comprising a layer of insoluble,
cross-linked proteins assembled at the plasma membrane of
keratinocytes in the outermost epidermal layers, is indispensable
for epidermal barrier function (for reviews see Kalinin et al.,
2001, 2002). Two of the earliest CE precursors to be expressed
during epidermal terminal differentiation are envoplakin and
periplakin, which localize to desmosomes and the interdes-
mosomal plasma membrane (Ruhrberg et al., 1996, 1997;
DiColandrea et al., 2000). Transglutaminase 1 catalyses iso-
peptide bonds between envoplakin, periplakin, and a third
CE precursor, involucrin, resulting in the formation of a
scaffold to which other precursors are added to form the
mature CE (Kalinin et al., 2001).
Envoplakin and periplakin belong to the plakin family of
cytolinker proteins, whose other members include desmo-
plakin, plectin, and bullous pemphigoid antigen 1 (for reviews
see Fuchs and Karakesisoglou, 2001; Leung et al., 2002).
Plakins link cytoskeletal networks to each other and to
membrane-associated adhesive sites. The domains required
for association with desmosomes and hemidesmosomes or
the actin cytoskeleton are located in the NH
 
2
 
 terminus,
whereas those that bind intermediate filaments (IFs) or mi-
crotubules are found in the COOH terminus. The central
coiled coil rod domain mediates homodimerization. Envo-
plakin and periplakin are unusual in that they can hetero-
dimerize, and envoplakin appears to depend on periplakin
both for association with the plasma membrane and for stable
IF binding (Ruhrberg et al., 1997; DiColandrea et al., 2000;
Karashima and Watt, 2002).
Although periplakin lacks a consensus actin-binding domain,
its NH
 
2
 
 terminus associates with cortical actin at the inter-
desmosomal plasma membrane, allowing it to act as a scaf-
fold for CE assembly (DiColandrea et al., 2000). In this
paper, we set out to define the mechanism by which peri-
plakin associates with the plasma membrane.
 
Results and discussion
 
Defining the domains of periplakin necessary 
for plasma membrane localization
 
The 495 NH
 
2
 
-terminal amino acids of periplakin (P1/2N),
encoding the NN, Z, Y, and X subdomains, are sufficient
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for desmosomal and interdesmosomal plasma membrane lo-
calization (DiColandrea et al., 2000). At the interdesmo-
somal plasma membrane, P1/2N is concentrated at mi-
crovilli, defined here as actin-rich projections from the apical
surface of cultured keratinocytes (DiColandrea et al., 2000;
Fig. 1 C). Further deletion constructs were generated to pre-
cisely define the membrane interaction region (Fig. 1 A).
Amino acids 1–133 of periplakin (P133), encoding the en-
tire NN subdomain and the 16 amino acids that precede it,
colocalized as efficiently as P1/2N (Fig. 1 C) with cortical
actin (Fig. 1, F–H) and CD44 (not depicted) at microvilli.
Addition of Latrunculin B caused redistribution of both
P133 and P1/2N with actin (Fig. 1, I–K; DiColandrea et al.,
2000).
Sequence analysis predicts that the NN subdomain com-
prises four short 
 
 
 
-helices that fold into an antiparallel bun-
dle (Fig. 1 B; Ruhrberg et al., 1997). Removal of the 16
amino acids preceding the NN subdomain prevented ef-
ficient localization to microvilli (P16-133; not depicted).
When amino acids 1–63 of periplakin were expressed in ke-
ratinocytes, no specific localization to microvilli was ob-
served (Fig. 1, D and E, P63). Amino acids 1–80 could lo-
calize to microvilli, but not in all transfectants (P80; not
depicted). We conclude that P133 is the minimal region of
periplakin able to localize efficiently to the plasma mem-
brane and associate with the cortical actin cytoskeleton.
 
Identification of kazrin as a novel periplakin interactor
 
Because periplakin does not directly bind actin (not de-
picted), we performed a yeast two-hybrid screen to identify
proteins that bind to the NH
 
2
 
 terminus of periplakin and
might mediate its association with actin or the plasma mem-
brane. Using P133 as bait and a human keratinocyte cDNA
library as prey, we identified a single clone. The insert DNA
encoded a 279 amino acid protein in frame to the GAL4-
AD domain that lacked a translation initiation codon.
Figure 1. Periplakin deletion analysis. 
(A) Schematic diagram of the periplakin 
constructs used for transient transfec-
tions. Domain nomenclature is described 
by Ruhrberg et al. (1997). All constructs 
had COOH-terminal HA tags. (B) Sec-
ondary structure predictions based on 
algorithms of Chou/Fasman and Garnier/
Robson of the NH2-terminal 133 amino 
acids of periplakin. (C–K) Confocal pro-
jections of primary keratinocytes trans-
fected with periplakin NH2-terminal 
constructs (C, P1/2N; D and E, P63; F–K, 
P133). (I–K) Cells were treated with 
Latrunculin B (200 ng/ml, 3 h) before 
fixation. Green, anti-HA; red, phalloidin-
TRITC. C, E, H, and K show merged 
images. Bar: (C–H) 20  m; (I–K) 10  m. 
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A BLAST search of the nucleotide sequence of the positive
clone resulted in identification of four alternatively spliced
isoforms encoded by the human gene, which we have named
kazrin (Fig. 2). The kazrin gene is located on human chro-
mosome 1 (band 1p36.21) and mouse chromosome 4 (band
4E1). Each isoform of human kazrin has one of four possible
first exons, referred to as 1a, 1b, 1c, or 1d (Fig. 2 A). Exons 2
to 8 are spliced together and are preceded by one of the four
alternative first exons (Fig. 2 A and Fig. S1 A, available at
http://www.jcb.org/cgi/content/full/jcb.200312123/DC1).
Exons 1a and 1b contain in-frame start codons resulting in
proteins of 421 (kazrin A) and 414 (kazrin B) amino acids,
respectively (Fig. S1 A). The coding sequence of kazrin splice
forms containing 1c or 1d begins within exon 2, resulting in
a protein of 327 amino acids. Thus, kazrin C and D have
identical amino acid sequences and are referred to as kazrin
C for simplicity. The region of kazrin identified in the yeast
two-hybrid screen corresponds to amino acids 49 to 327 of
kazrin C. BLAST searches against the mouse genome re-
vealed the presence of sequences with homology to each of
the alternative first exons 1a, 1b, 1c, 1d, and exons 2–8.
Thus far, however, only sequences corresponding to kazrin a
and b transcripts are present in mouse EST databases.
Human kazrin is 98% identical at the protein level to the
predicted amino acid sequence of mouse kazrin over the re-
gion encompassing human kazrin C. The unique protein se-
quences at the NH
 
2
 
 termini of kazrin A and B are also highly
conserved between mouse and human (Fig. S1 B).
All protein isoforms of kazrin are hydrophilic and lack any
predicted transmembrane domain (Fig. S2, available at http:
//www.jcb.org/cgi/content/full/jcb.200312123/DC1). The
NH
 
2
 
-terminal portion of the protein is a highly 
 
 
 
-helical re-
gion predicted to form a coiled coil, whereas the COOH-
terminal half of kazrin is predicted to contain a small 
 
 
 
sheet, multiple 
 
 
 
-turns, and three 
 
 
 
-helical stretches (Fig. 2
B and Fig. S2). There is weak homology between the kazrin
NH
 
2
 
-terminal 
 
 
 
-helical region and the 
 
 
 
-helical coiled coil
domain of ERM proteins (Bretscher et al., 2002). Kazrin A
and B have a leucine zipper-like motif encoded by exon 2,
upstream of the translation initiation codon for kazrin C
(Fig. 2 A and Fig. S1 A) that could potentially mediate
dimerization or interactions with other proteins. The unique
NH
 
2
 
 termini have different potential phosphorylation sites.
All kazrin isoforms have a putative NLS located near the
COOH terminus (Fig. 2 A and Fig. S1 A).
To map the region of kazrin responsible for periplakin
binding, deletion mutants of kazrin were tested for their
ability to bind P133 by yeast two-hybrid analysis (Fig. 2 B).
Amino acids 89 to 239 of kazrin C, encompassing part of
the 
 
 
 
-helical region and a series of 
 
 
 
-turns, were sufficient
to mediate the interaction with amino acids 1 to 133 of
periplakin.
To validate the association of kazrin with P133, kazrin-
GST fusion proteins were constructed and used in pull-
down assays with human keratinocyte lysates as a source of
periplakin (Fig. 2 C). The partial clone obtained in the yeast
two-hybrid screen (KC
 
 
 
), full-length kazrin A, B, and C all
bound periplakin. Envoplakin was detected in the pull-
downs, suggesting that kazrin can associate with periplakin/
envoplakin heterodimers. Desmoplakin was readily detected
in keratinocyte lysates, but was either undetectable or weakly
detectable in the pull-downs (Fig. 2 C).
Figure 2. Kazrin and its interaction 
with periplakin. (A) Intron-exon organi-
zation of the kazrin gene, drawn to 
scale. Arrows, translation initiation sites; 
diagonal lines, 320 kb gap;  , leucine 
zipper-like domain; black bar spanning 
exons 3 to 5,  -helical region; asterisk, 
putative NLS sequence. TGA, translation 
termination codon; AATAAA, polyade-
nylation signal. Sequence data available 
from GenBank/EMBL/DDBJ under 
accession no. AY505119, AY505120, 
AY505121, and AY505122, correspond-
ing to kazrin isoform a, b, c, and d, 
respectively. (B) Secondary structure 
predictions of kazrin C, based on algo-
rithms of Chou/Fasman and Garnier/
Robson, and two-hybrid analysis of 
interaction between P133 and kazrin 
deletion constructs. Numbers correspond 
to amino acids of kazrin C. Interactions 
scored positive if yeast grew on selective 
medium. (C) Immunoblots of GST pull-
downs from keratinocyte lysates with 
immobilized GST-kazrin A (KA), GST-
kazrin B (KB), GST-kazrin C (KC), GST-
kazrin C aa 49–327 (KC ), or GST alone (GST). Blots were probed with antibodies specific for periplakin (Ppl; TD2), envoplakin (Evpl; CR5), 
or desmoplakin (Dp; 115F). As a control, 4% of cell lysate used in the pull-downs was loaded on gel (Extr). (D) Coimmunoprecipitation of 
kazrin C with P133. Cos-7 cells were transiently transfected with kazrin C-FLAG (K) together with empty vector (V) or P133-HA (P). Proteins 
were immunoprecipitated with anti-HA Y11 (HA IP), and immunoblots were probed with anti-FLAG mAb M2. As a control, 5% of cell lysate 
used in the immunoprecipitation was run in parallel (lysate). Positions of kazrin (K) and immunoglobulin light chain (Ig) are indicated. 
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To examine whether or not kazrin and periplakin were ca-
pable of associating in intact cells, we cotransfected FLAG-
tagged kazrin C and HA-tagged P133 into Cos-7 cells (Fig.
2 D). The transfected proteins were detected in cell lysates
with the appropriate antibodies (Fig. 2 D, lysate; and not
depicted). Kazrin C was coimmunoprecipitated with P133,
as detected by Western blotting with anti-FLAG antibody
(Fig. 2 D, HA IP).
 
Expression of kazrin mRNA and alternatively spliced 
transcripts
 
Kazrin expression was analyzed by real-time PCR using
cDNA preparations from multiple human tissues and cells
(Fig. S3, available at http://www.jcb.org/cgi/content/full/
jcb.200312123/DC1) and primers common to all four
kazrin splice forms. Kazrin was detected in many tissues that
have been demonstrated to express periplakin, including
bladder, brain, colon, heart, kidney, liver, lung, pancreas,
placenta, and small intestine (Ruhrberg et al., 1997; Aho
and Kazerounian, 2003).
To determine if the splice variants of kazrin are differen-
tially expressed, RT-PCR was performed on RNA isolated
from primary human keratinocytes (Fig. 3 A, HK), primary
dermal fibroblasts (HDF), and from three human cell lines,
A431 (epidermoid carcinoma), EJ/28 (bladder carcinoma),
and JAR (placental trophoblastoma). A forward primer that
binds specifically within each first exon, 1a, 1b, 1c, or 1d,
was used in combination with a reverse primer that binds se-
quences in exons 3 and 4 (Fig. 3 A). Kazrin b and d tran-
scripts were expressed in all cell types examined. Kazrin a
transcript was detectable in all cell types except A431. Kaz-
rin c transcript was only detected in JAR cells and human
dermal fibroblasts. Thus, kazrin mRNA splicing differs be-
tween cell types, and keratinocytes are predicted to express
all three protein isoforms.
In situ hybridization was performed to compare kazrin and
periplakin expression in mouse skin and tongue (Fig. 3, B–E),
using 
 
 
 
 actin as a positive control (not depicted). Periplakin
and kazrin were expressed in the interfollicular epidermis and
hair follicles (Fig. 3, B and D). Kazrin was also detected in
the dermis (Fig. 3 B). Up-regulation of periplakin in the su-
prabasal layers of tongue epithelium was readily observed
(Fig. 3 E). In contrast, kazrin mRNA was expressed uni-
formly in basal and suprabasal layers (Fig. 3 C).
 
Expression and subcellular localization of kazrin protein
 
Affinity-purified rabbit anti-kazrin (LS4) recognized bands
of 
 
 
 
47 and 37 kD on Western blots of cell lysates (Fig. 4
A). These bands correspond to the predicted molecular
masses of kazrin A (46.7 kD), kazrin B (46 kD), and kazrin
C (37 kD). A431 cells express kazrin b but not kazrin a tran-
script (Fig. 3 A); nevertheless the 47-kD protein band from
A431 lysates appeared as a doublet, suggesting kazrin may
undergo posttranslational modification (Fig. 4 A). Although
A431, EJ/28, and human keratinocytes expressed similar
levels of kazrin d transcript (Fig. 3 A), the 37-kD form of
kazrin protein was relatively less abundant in human kerati-
nocytes, an indication of differential regulation at the trans-
lational or posttranslational level.
To determine whether or not kazrin, like periplakin, can
be incorporated into the CE, confluent keratinocyte cultures
were treated with 0.04% Triton X-100 for 5 h to induce en-
velope assembly (Fig. 4 B). Proteins that become cross-
linked into the CE are no longer extractable in SDS and re-
ducing agents. Transglutaminase-mediated cross-linking is
inhibited by 20 mM cystamine (Ruhrberg et al., 1997).
Periplakin and kazrin were readily detected in control cell ly-
sates in the presence (Fig. 4 B, Cy) or absence (Fig. 4 B, 
 
 
 
)
of cystamine. Both proteins became nonextractable after
Triton X-100 incubation (Fig. 4 B, T), and this was inhib-
ited by cystamine (Fig. 4 B, Cy/T). We conclude that kazrin
can be incorporated into the CE.
Consistent with the in situ hybridization results (Fig. 3, B
and C), kazrin protein was detected in all layers of human
Figure 3. Kazrin mRNA expression. (A) RT-PCR analysis of kazrin mRNA. Forward primers specific for each of the four alternatively spliced 
first exons were used in combination with a reverse primer common to all splice forms. As a control for the total level of kazrin transcripts, a 
forward primer was used that binds within exon 2 (kazrin all) in combination with the reverse primer. Primers specific for glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) were used to control for input level of mRNA. (B–E) In situ hybridization of kazrin (B and C) and periplakin 
(D and E) using 
35S-labeled antisense riboprobes in wild-type mouse skin (B and D) and tongue (C and E). Arrowheads show junction between 
epithelium and connective tissue. Bar, 100  m. 
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interfollicular epidermis and in the hair follicle (Fig. 4, C
and E). Periplakin was up-regulated in the suprabasal layers
of the epidermis (Fig. 4 D). In the cell layers that coex-
pressed kazrin and periplakin, kazrin localized to cell–cell
borders, but in the basal layer kazrin was more diffusely lo-
calized (Fig. 4, C and I). Double labeling for kazrin and
periplakin or desmoplakin showed extensive colocalization
at cell–cell borders (Fig. 4, E–I). In some cells, kazrin was
detected in the nucleus (Fig. 4 H). Because both kazrin and
periplakin (van den Heuvel et al., 2002) have a putative
NLS it is possible that their interaction is not confined to
the plasma membrane.
 
Kazrin is a desmosome component
 
Immunoelectron microscopy of human interfollicular epi-
dermis confirmed that kazrin (Fig. 4, K and L), like des-
moplakin (Fig. 4 J), was found at desmosomes. Some nuclei
also showed kazrin labeling (Fig. 4 M). Whereas periplakin
is found in association with keratin filaments (Ruhrberg et
al., 1997), kazrin had a more diffuse cytoplasmic localization
(not depicted).
In differentiating primary human keratinocytes, kazrin
was observed at cell–cell borders and, to a variable degree, in
the nucleus (Fig. 5, A–L). In stratified cultures, large num-
bers of desmosomes assemble at the interface between the
apical surfaces of basal layer cells and the basal surfaces of su-
prabasal cells. Kazrin partially colocalized with desmoplakin
and periplakin at the desmosomes and with periplakin at
the interdesmosomal plasma membrane (Fig. 5, A–H). Kaz-
rin was localized to puncta, corresponding to desmosomes,
where IFs in neighboring cells aligned (Fig. 5, I–L). The
subcellular distribution of kazrin was indistinguishable in
keratinocyte lines generated from periplakin-null and wild-
type mice (Fig. 5, M–P), demonstrating that kazrin was
not dependent on periplakin for its localization. The shift
in kazrin localization to cell–cell borders in differentiating
periplakin-null keratinocytes suggests an association with
additional desmosomal components that are up-regulated
during terminal differentiation.
 
Localization of kazrin protein isoforms
 
NH
 
2
 
-terminally HA-tagged constructs encoding kazrin A, B,
or C were transiently transfected into primary human kerati-
nocytes (Fig. 5, Q–U). All three isoforms had similar subcellu-
lar distributions (Fig. 5, Q–S) and were observed predomi-
nantly at the apical plasma membrane (Fig. 5, T and U), with
Figure 4. Kazrin protein expression and cellular localization. (A) Immunoblot of protein lysates from A431, EJ/28, and human keratinocytes 
(HK) with anti-kazrin (LS4) or anti-actin (loading control). The 37-kD band corresponds to kazrin C (C); the 47-kD doublet corresponds to 
kazrin A and B (A/B). Molecular mass markers (kD) are indicated. White line indicates that intervening lanes have been spliced out. (B) CE 
incorporation of periplakin and kazrin. Keratinocytes were incubated in the absence ( ) or presence (T) of Triton X-100, cystamine (Cy), or 
cystamine and Triton X-100 (Cy/T). Immunoblots were probed with antibodies to kazrin (46 kD isoforms A/B are shown; K) and periplakin (P). 
(C–I) Immunofluorescence staining of human interfollicular epidermis (C and D) and hair follicles (E–I) with antibodies specific for kazrin (K; 
green in C, E, and G–I), periplakin (PPL; D, green; and I, red), or desmoplakin (DP; F–H, red). (C and D) Nuclei were labeled with TO-PRO-3 
(blue). (G) Boxed area is enlarged in H. Bars: (C–G) 50  m; (H and I) 6  m. (J–M) Immunogold EM of human breast epidermis with anti-
desmoplakin (J) and anti-kazrin (K–M). Arrows indicate 10-nm gold particles localized at desmosomes (J–L) or in nucleus (M). Bar: (J) 200 nm; 
(K) 330 nm; (L) 120 nm; (M) 487 nm. 
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some signal detected in the cytoplasm and the nucleus (not de-
picted). All isoforms could colocalize with cortical actin-based
membrane structures including microvilli (Fig. 5, Q–U).
Although several proteins have been found to associate
with the COOH terminus of periplakin (Aho and Kazerou-
nian, 2003), kazrin is the first protein identified that binds
to the NH
 
2
 
 terminus. The association of periplakin and
kazrin with actin and desmosomes, and the binding of peri-
plakin to IFs, suggests that these proteins may be involved in
the interplay between adherens junctions and desmosomes
(Vasioukhin et al., 2001; Huen et al., 2002; Weber and
Bement, 2002).
 
Materials and methods
 
Yeast two-hybrid screen and isolation of kazrin cDNA
 
Yeast two-hybrid protein interaction experiments and library screenings
were performed using the MATCHMAKER GAL4 two-hybrid system 3 (BD
Biosciences) according to the manufacturer’s instructions. The AH109
yeast host strain was cotransformed with the bait plasmid (P133 in
pGBKT7) and a human keratinocyte MATCHMAKER cDNA library in the
cloning vector pGAD10.
 
DNA clones and constructs
 
BLAST 2.0 (National Center for Biotechnology Information) and BLAT
(Golden Path Genome Browser) programs were used to search EST data-
bases and genome sequences. IMAGE clones of cDNAs encoding mouse
periplakin (No. 349663), mouse kazrin a (No. 3667377), human kazrin a
(No. 6180253), human kazrin b (No. 4556194), human kazrin c (No.
4651187), or human kazrin d (No. 4472821) were obtained from the Med-
ical Research Council Geneservice Resource Centre and confirmed by se-
quencing the 5
 
 
 
 UTRs and coding regions. See the online supplemental
material for cloning strategies and PCR primer sequences.
 
Cell culture and transfection
 
Normal neonatal human keratinocytes (strain kq passages 3–6) and sponta-
neously immortalized wild-type and periplakin-null (Aho et al., 2004)
mouse keratinocytes were cultured as described previously (DiColandrea
et al., 2000). All other cells were maintained in DME with 10% FCS. Tran-
sient transfection was performed as described previously (Karashima and
Watt, 2002).
 
Antibodies
 
The following primary antibodies were used as described previously (Ru-
hrberg et al., 1997; Karashima and Watt, 2002): CR5 (rabbit anti-
envoplakin), 11-5F (mouse monoclonal anti-desmoplakin; gift of D.R.
Garrod, University of Manchester, Manchester, UK), TD2 (rabbit anti-
periplakin), AC-40 (mouse monoclonal anti-actin; Sigma-Aldrich), AE11
(mouse monoclonal anti-periplakin; gift of H. Sun, New York University
Figure 5. Kazrin localization in cultured 
keratinocytes. Human keratinocytes 
(A–L) and keratinocytes from wild-type 
(M and N) or periplakin null (O and P) 
mice were immunolabeled with anti-
bodies to kazrin (K; A–J and M–P, green) 
and periplakin (PPL; A–D, red; and K 
and L, green), desmoplakin (DP; E–H 
and M–P, red) or keratins (IF; I–L, red). 
Boxes in A, E, I, K, M, and O are enlarged 
in B–D, F–H, J, L, N, and P, respectively. 
Bar: (A, E, I, K, M, and O) 20  m; (B–D 
and F–H) 7  m; (J and L) 5.4  m; (N and P) 
5  m. (Q–U) Kazrin isoforms (Q, kazrin 
A; R, kazrin B; S–U, kazrin C) with 
NH2-terminal HA tags were transiently 
transfected into primary human kerati-
nocytes. (Q–U) green, anti-HA; red, 
phalloidin-TRITC. Q–S are composite 
images of z-stacks. Arrowheads in S 
indicate position of orthogonal view 
shown in T. Area boxed in S is shown 
as single confocal slice in U. Bar: (Q–S) 
20  m; (T) 11.5  m; (U) 6  m. 
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Medical School, New York, NY), Y11 (rabbit antiserum to HA; Santa Cruz
Biotechnology, Inc.), M2 (mouse monoclonal anti-FLAG; Sigma-Aldrich),
and LP34 (mouse monoclonal anti-keratin). Alexa 488– or Alexa 594–con-
jugated secondary antibodies (Molecular Probes) were used.
A peptide corresponding to the predicted COOH-terminal 20 amino ac-
ids (DPGLFDGTAPDYYIEEDADW) of human and mouse kazrin was used
to generate rabbit anti-LS4. LS4 was affinity purified on a column contain-
ing its immunogen coupled to Amino-Link Coupling Gel (Perbio).
 
GST pull down assay
 
Fusion proteins were expressed in 
 
Escherichia coli
 
 BL21 cells and puri-
fied from cell extracts using Glutathione Sepharose 4B (Amersham Bio-
sciences). Confluent cultures of human keratinocytes were extracted in
ice-cold buffer (50 mM NaCl, 300 mM sucrose, 10 mM Pipes, pH 6.8, 3
mM MgCl
 
2
 
, and 0.5% Triton X-100) containing 10 mM EDTA and protease
inhibitors (Roche). Protein samples were incubated by rotation at 4
 
 
 
C for
3–4 h with 10 
 
 
 
g GST or GST-fusion proteins prebound to Glutathione
Sepharose 4B. Precipitates were washed in ice-cold PBS and boiled in
SDS-PAGE sample buffer containing 10% 
 
 
 
-mercaptoethanol before gel
electrophoresis.
 
Immunodetection
 
Immunofluorescence staining was performed as described previously (Di-
Colandrea et al., 2000). Samples were examined on a laser scanning con-
focal microscope (model LSM 510 equipped with 458-nm, 488-nm, and
633-nm lasers; Carl Zeiss MicroImaging, Inc.) with a 63
 
 
 
 plan-APO-
CHROMAT oil immersion lens (numerical aperture 1.4) or 40
 
  
 
C-APO-
CHROMAT water immersion lens (numerical aperture 1.2). Digital images
were prepared using Adobe Photoshop 6.0 and Imaris 3.1. Immunogold
electron microscopy was performed on thin sections of high pressure-fro-
zen and freeze-substituted adult breast epidermis (Ruhrberg et al., 1996).
Immunoprecipitation and immunoblotting were performed as described
previously (Ruhrberg et al., 1996).
 
In situ hybridization and RT-PCR
 
In situ hybridization was performed with sections of PFA-fixed, paraffin-
embedded mouse tissues and 
 
35
 
S-labeled riboprobes described in the on-
line supplemental material.
Total RNA was prepared from cultured cells using TriReagent (Molecu-
lar Research Center, Inc.). The SuperScript One-Step RT-PCR with Plati-
num Taq kit (Invitrogen) was used to determine expression of human
kazrin mRNA in a panel of primary cells and cell lines. Details of primer
sequences can be found in the online supplemental material.
 
Online supplemental material
 
Fig. S1 shows kazrin nucleotide and amino acid sequences. Fig. S2 shows
analysis of predicted structure and hydrophilicity of kazrin. Fig. S3 shows
real-time PCR analysis of kazrin expression. Online supplemental material
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